These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
680 related articles for article (PubMed ID: 17848610)
1. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005). Villar E; Chang SH; McDonald SP Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610 [TBL] [Abstract][Full Text] [Related]
2. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry. McDonald SP; Russ GR; Kerr PG; Collins JF; Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029 [TBL] [Abstract][Full Text] [Related]
3. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Hoffmann F; Haastert B; Koch M; Giani G; Glaeske G; Icks A Nephrol Dial Transplant; 2011 May; 26(5):1634-40. PubMed ID: 20959344 [TBL] [Abstract][Full Text] [Related]
4. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study). Martínez-Castelao A; Gòrriz JL; Garcia-López F; López-Revuelta K; De Alvaro F; Cruzado JM; J Nephrol; 2004; 17(4):544-51. PubMed ID: 15372417 [TBL] [Abstract][Full Text] [Related]
5. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. ; Stewart JH; McCredie MR; Williams SM Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584 [TBL] [Abstract][Full Text] [Related]
6. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy. Grace BS; Clayton P; McDonald SP Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505 [TBL] [Abstract][Full Text] [Related]
7. [Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies]. Pérez García R; Rodríguez Benítez P; Dall'Anesse C; Gómez Campderá F; Valderrábano F An Med Interna; 2001 Apr; 18(4):175-80. PubMed ID: 11496535 [TBL] [Abstract][Full Text] [Related]
8. Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre. Abderrahim E; Zouaghi K; Hedri H; Ben Abdallah T; Ben Hamida F; Kaaroud H; Goucha R; Ben Abdallah N; Khiari K; El Younsi F; Ben Moussa F; Kheder A; Ben Maïz H Diabetes Metab; 2001 Nov; 27(5 Pt 1):584-90. PubMed ID: 11694858 [TBL] [Abstract][Full Text] [Related]
9. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169 [TBL] [Abstract][Full Text] [Related]
10. Improved survival of type 2 diabetic patients on renal replacement therapy in Finland. Kervinen M; Lehto S; Ikäheimo R; Karhapää P; Grönhagen-Riska C; Finne P Nephrol Dial Transplant; 2010 Mar; 25(3):892-6. PubMed ID: 19846391 [TBL] [Abstract][Full Text] [Related]
11. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002. ; Stewart JH; McCredie MR; Williams SM Diabet Med; 2006 Dec; 23(12):1364-9. PubMed ID: 17116189 [TBL] [Abstract][Full Text] [Related]
12. Regional and social inequalities in chronic renal replacement therapy in Denmark. Hommel K; Rasmussen S; Kamper AL; Madsen M Nephrol Dial Transplant; 2010 Aug; 25(8):2624-32. PubMed ID: 20207710 [TBL] [Abstract][Full Text] [Related]
13. Duration of end-stage renal disease and kidney transplant outcome. Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892 [TBL] [Abstract][Full Text] [Related]
14. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades. Cao C; Hellermann JP; Weber M; Ambühl PM Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627 [TBL] [Abstract][Full Text] [Related]
15. Patients with diabetic nephropathy on renal replacement therapy in England and Wales. Nitsch D; Burden R; Steenkamp R; Ansell D; Byrne C; Caskey F; Roderick P; Feest T QJM; 2007 Sep; 100(9):551-60. PubMed ID: 17681992 [TBL] [Abstract][Full Text] [Related]
16. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Evans M; Fryzek JP; Elinder CG; Cohen SS; McLaughlin JK; Nyrén O; Fored CM Am J Kidney Dis; 2005 Nov; 46(5):863-70. PubMed ID: 16253726 [TBL] [Abstract][Full Text] [Related]
17. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245 [TBL] [Abstract][Full Text] [Related]
18. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases. Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW Nephrol Dial Transplant; 2013 Feb; 28(2):455-61. PubMed ID: 23182810 [TBL] [Abstract][Full Text] [Related]
19. [Has the incidence of end-stage renal disease increased in diabetic patients? A center-based longitudinal study over 10 years]. Van Landeghem MA Med Klin (Munich); 2005 May; 100(5):241-5. PubMed ID: 15902377 [TBL] [Abstract][Full Text] [Related]
20. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus. Schiel R; Heinrich S; Steiner T; Ott U; Stein G Nephrol Dial Transplant; 2005 Mar; 20(3):611-7. PubMed ID: 15689368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]